The Journal of Immunology

J Immunol. 2026 Jun 7;215(6):vkag110. doi: 10.1093/jimmun/vkag110. ABSTRACT The cytokines interleukin (IL)-22 and IL-17 are secreted by innate and adaptive immune cells to drive “type III” responses that protect against extracellular pathogens, promote mucosal barrier integrity, and foster microbiota homeostasis. However, dysregulation of IL-22 and/or IL-17 contributes to autoimmunity, chronic inflammation, and malignancy. Thus, a … Read more

J Immunol. 2026 Jun 7;215(6):vkag091. doi: 10.1093/jimmun/vkag091. ABSTRACT Viral or tumor persistence is often associated with CD8 T cell “exhaustion,” a differentiation process characterized by co-inhibitory receptor upregulation and loss of effector function. Recent data show that “exhausted” T cells are a heterogenous population that includes a progenitor subset that transitions through an intermediate state … Read more

J Immunol. 2026 Jun 7;215(6):vkag074. doi: 10.1093/jimmun/vkag074. ABSTRACT Messenger RNA (mRNA) vaccines effectively induce protective immunity, but antigen-specific CD8+ T cell responses exhibit limited persistence. In this study, we aimed to assess CD8+ T cell responses following a third dose of the Pfizer BNT162b2 COVID-19 vaccine and identify factors contributing to their longevity. Using HLA … Read more

J Immunol. 2026 Jun 7;215(6):vkag130. doi: 10.1093/jimmun/vkag130. ABSTRACT Sepsis is the leading cause of death in hospitals and is very common in intensive care units (ICUs). Sleep is frequently interrupted in the hospital setting, especially within the ICU. Patients who sleep poorly have worse outcomes, such as increased mortality and longer hospital stays; however, the … Read more

J Immunol. 2026 Jun 7;215(6):vkag124. doi: 10.1093/jimmun/vkag124. ABSTRACT Group 2 innate lymphoid cells (ILC2s) are thought to develop in the bone marrow and fetal liver. However, increasing evidence supports the presence of thymic ILC2s in mice and humans. In this study, we introduce a novel fate-mapping mouse model designed to track thymic ILC2s in peripheral … Read more

J Immunol. 2026 Jun 7;215(6):vkag117. doi: 10.1093/jimmun/vkag117. ABSTRACT Mucosal immunity is paramount for combating respiratory infections, but conventional vaccination methods, such as intramuscular injection, often struggle to induce it. Although direct mucosal vaccination is effective, it carries an increased risk of respiratory adverse effects, making it particularly challenging for individuals with chronic respiratory diseases. Consequently, … Read more

J Immunol. 2026 Jun 7;215(6):vkag122. doi: 10.1093/jimmun/vkag122. ABSTRACT Interferon-induced transmembrane (IFITM) proteins underpin antiviral responses, yet their role in bacterial infections remains underexplored, particularly for parasites. We probed the role of IFITM1 in Mycobacterium tuberculosis (Mtb), Listeria monocytogenes (Lm), and Leishmania major infection using IFITM1 knockout mice. Notably, IFITM1 was upregulated in murine and human … Read more

J Immunol. 2026 May 14;215(5):vkag069. doi: 10.1093/jimmun/vkag069. ABSTRACT Burkholderia thailandensis (B. thailandensis) is an emerging pathogen. Although it has not yet caused large-scale outbreaks, severe infections can lead to sepsis. Currently, there are no effective treatment strategies available, highlighting the urgent need to develop novel therapies. Progranulin (PGRN) is a multifunctional protein with complex roles … Read more

J Immunol. 2026 May 14;215(5):vkag047. doi: 10.1093/jimmun/vkag047. NO ABSTRACT PMID:42229912 | DOI:10.1093/jimmun/vkag047

J Immunol. 2026 May 14;215(5):vkaf166. doi: 10.1093/jimmun/vkaf166. NO ABSTRACT PMID:42226503 | DOI:10.1093/jimmun/vkaf166